134 related articles for article (PubMed ID: 14754878)
1. COX-2 gene promoter haplotypes and prostate cancer risk.
Panguluri RC; Long LO; Chen W; Wang S; Coulibaly A; Ukoli F; Jackson A; Weinrich S; Ahaghotu C; Isaacs W; Kittles RA
Carcinogenesis; 2004 Jun; 25(6):961-6. PubMed ID: 14754878
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
3. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
4. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.
Kang S; Kim YB; Kim MH; Yoon KS; Kim JW; Park NH; Song YS; Kang D; Yoo KY; Kang SB; Lee HP
Cancer Lett; 2005 Jan; 217(1):11-6. PubMed ID: 15596291
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
[TBL] [Abstract][Full Text] [Related]
7. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
9. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
10. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
12. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.
Moon S; Holley S; Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
Ann Hum Genet; 2006 Mar; 70(Pt 2):226-36. PubMed ID: 16626332
[TBL] [Abstract][Full Text] [Related]
13. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
[TBL] [Abstract][Full Text] [Related]
14. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
15. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
16. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
18. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
19. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
[TBL] [Abstract][Full Text] [Related]
20. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
